US · guidance
CMS SOM App. H, Tag V358
ANSI/AAMI RD47:2002/A1:2003 Requirements as Adopted by Reference 42 CFR
494.50(b)(1)
13.4 Clinical results (monitoring patient results; Kt/V)
Monitoring of relevant patient results is recommended to ensure that all parameters
relating to hemodialyzer clearance are being met. Specifically, examination of urea
reduction ratio (URR) or Kt/V over time is necessary. The failure of these results to meet
the expectations of the dialysis prescription should be investigated. Deterioration of a
patient’s clinical condition or variability of routine dialysis procedures (heparinization,
ultrafiltration, dose of erythropoietin stimulating agent) [requires] an investigation of all
practices, including reuse. Reports of investigations should be filed in the complaint log.
Page 161 of 420
Interpretive Guidance § 494.50(b)(1)
AAMI Rationale for the Development and Provisions of this Recommended Practice
A.13.4 Clinical results
Critical assessment of chemistries and the delivered dose of dialysis (Kt/V or urea reduction
ratio), as is done monthly, provides a clear trend line to assess treatment. This scrutiny of the
patient’s treatment and course is the primary confirmation that hemodialyzer performance
anticipated from TCV or other indirect estimation is accurate and adequate. The overall
effectiveness of the entire treatment, not only the clearance of the dialyzers, is measured. No
other measure of the effectiveness of new or reused dialyzers is as clear or relevant. Trend lines
developed from this data characterize the quality of therapy. . . If the practitioner has concerns
for “middle molecules” or other clinical parameters, these factors should also be part of the
assessment of the delivered therapy.
There are many reasons for an apparent reduction in the mass transfer of urea, other than
decreased hemodialyzer clearance as a result of inadequate reprocessing (such as recirculation,
decreased dialysis time or blood flow rate, or an inappropriate dialysis prescription). To
document adequate mass transfer, parallel measurements of pre- and post-creatinine levels are
helpful. When problems develop with any patient or group of patients, monitoring intensity
should be increased, and other methods should be used to analyze the problem and define
corrective action.
History
Rev.
Provenance
- Source
- cms.gov
- Retrieved
- 2026-07-22
- Edition
- som-2026-07-22
- Content hash
04cb7cde62cb6512ebd34b8a21f2913cd6b931446e3064f4c9c3d3c59d9016f5
The link goes to the issuing authority’s own document — the one we read to produce this record. Where a source publishes whole titles rather than sections, your browser may need a moment to jump to the provision.
Unofficial copy of government-published law, reproduced from official sources with full provenance. Not an official publication; verify against official sources before relying on it in a filing. Records in the 'guidance' corpus, and only that corpus, are sub-regulatory (interpretive guidelines, survey procedures) and are not binding law. Validity bounds follow each jurisdiction's declared temporalBasis.